Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Saved in:
| Title: | Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial. |
|---|---|
| Authors: | Ramalingam, Suresh S1 ssramal@emory.edu, Jänne, Pasi A2, Mok, Tony3, O'Byrne, Kenneth4, Boyer, Michael J5, Von Pawel, Joachim6, Pluzanski, Adam7, Shtivelband, Mikhail8, Docampo, Lara Iglesias9, Bennouna, Jaafar10, Zhang, Hui11, Liang, Jane Q12, Doherty, Jim P13, Taylor, Ian12, Mather, Cecile B12, Goldberg, Zelanna14, O'Connell, Joseph13, Paz-Ares, Luis15 |
| Source: | Lancet Oncology. Nov2014, Vol. 15 Issue 12, p1369-1378. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 99068085 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ramalingam%2C+Suresh+S%22">Ramalingam, Suresh S</searchLink><relatesTo>1</relatesTo><i> ssramal@emory.edu</i><br /><searchLink fieldCode="AR" term="%22Jänne%2C+Pasi+A%22">Jänne, Pasi A</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Mok%2C+Tony%22">Mok, Tony</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22O'Byrne%2C+Kenneth%22">O'Byrne, Kenneth</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Boyer%2C+Michael+J%22">Boyer, Michael J</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Von+Pawel%2C+Joachim%22">Von Pawel, Joachim</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Pluzanski%2C+Adam%22">Pluzanski, Adam</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Shtivelband%2C+Mikhail%22">Shtivelband, Mikhail</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Docampo%2C+Lara+Iglesias%22">Docampo, Lara Iglesias</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Bennouna%2C+Jaafar%22">Bennouna, Jaafar</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Hui%22">Zhang, Hui</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Liang%2C+Jane+Q%22">Liang, Jane Q</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Doherty%2C+Jim+P%22">Doherty, Jim P</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Taylor%2C+Ian%22">Taylor, Ian</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Mather%2C+Cecile+B%22">Mather, Cecile B</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Goldberg%2C+Zelanna%22">Goldberg, Zelanna</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22O'Connell%2C+Joseph%22">O'Connell, Joseph</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Paz-Ares%2C+Luis%22">Paz-Ares, Luis</searchLink><relatesTo>15</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Nov2014, Vol. 15 Issue 12, p1369-1378. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=99068085 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(14)70452-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1369 Titles: – TitleFull: Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ramalingam, Suresh S – PersonEntity: Name: NameFull: Jänne, Pasi A – PersonEntity: Name: NameFull: Mok, Tony – PersonEntity: Name: NameFull: O'Byrne, Kenneth – PersonEntity: Name: NameFull: Boyer, Michael J – PersonEntity: Name: NameFull: Von Pawel, Joachim – PersonEntity: Name: NameFull: Pluzanski, Adam – PersonEntity: Name: NameFull: Shtivelband, Mikhail – PersonEntity: Name: NameFull: Docampo, Lara Iglesias – PersonEntity: Name: NameFull: Bennouna, Jaafar – PersonEntity: Name: NameFull: Zhang, Hui – PersonEntity: Name: NameFull: Liang, Jane Q – PersonEntity: Name: NameFull: Doherty, Jim P – PersonEntity: Name: NameFull: Taylor, Ian – PersonEntity: Name: NameFull: Mather, Cecile B – PersonEntity: Name: NameFull: Goldberg, Zelanna – PersonEntity: Name: NameFull: O'Connell, Joseph – PersonEntity: Name: NameFull: Paz-Ares, Luis IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2014 Type: published Y: 2014 Identifiers: – Type: issn-print Value: 14702045 Numbering: – Type: volume Value: 15 – Type: issue Value: 12 Titles: – TitleFull: Lancet Oncology Type: main |
| ResultId | 1 |